GentryLO. Efficacy and safety of cefamandole plus either gentamicin or tobramycin in therapy of severe gram-negative bacterial infections. J Infect Dis1978; 137(Suppl): S144–9.
2.
KlasterskyJCappelRSwingsGVandenborreL. Bacteriological and clinical activity of the ampicillin/gentamicin and cephalothin/gentamicin combinations. Am J Med Sci1971; 262: 283–90.
3.
KlasterskyIHenriAVandenborreL. Antimicrobial activity of tobramycin and gentamicin used in combination with cephalothin and carbenicillin. Am J Med Sci1973; 266: 13–21.
4.
KlasterskyJNyamubeyaBVandenborreL. Antimicrobial effectiveness of kanamycin, aminosidin, BB-K8, sisomicin, gentamicin and tobramycin combined with carbenicillin or cephalothin against gram negative rods. J Med Microbiol1974; 7: 465–72.
5.
KellerHBircherJ. Miscellaneous antibiotics. In: DukesMNG, ed. Meyler's side effects of drugs, 9th ed.Amsterdam: Excerpta Medica, 1980;460.
6.
LuftFCEvanAP. Comparative effects of tobramycin and gentamicin on glomerular ultrastructure. J Infect Dis1980; 142: 910–4.
7.
EvanAPHuserJAuasthiPSRankinLILuftFC. Gentamicin-induced glomerular injury. In: NelsonIDGrassiC, eds. Current chemotherapy and infectious disease. Washington: American Society for Microbiology, 1980: 590–3.
8.
DahlgrenJGAndersonETHewittWL. Gentamicin blood levels: A guide to nephrotoxicity. Antimicrob Agents Chemother1975; 8: 58–62.
9.
GiamarellouHPetrikkosGDoudoulakiPDiakosGK. Prospective comparative evaluation of gentamicin alone and gentamicin plus various cephalosporins with respect to nephrotoxicity in humans. In: SiegenthalerWLuthyR, eds. Current chemotherapy. Washington: American Society for Microbiology, 1978: 968–70.
10.
Achieving optimal aminoglycoside serum concentrations in gram-negative infections. Schering Corporation Professional Literature, 1980: GA-866/11930905.
11.
CroninRE. Aminoglycoside nephrotoxicity: Pathogenesis and prevention. Clin Nephrol1979; 11: 251–6.
12.
HoigneRHopfBSonntagR. Penicillins, cephalosporins and tetracyclines. In: DukesMNG, ed. Meyler's side effects of drugs, 9th ed.Amsterdam: Excerpta Medica, 1980: 425.
13.
BirkheadHABriggsGBSaundersLZ. Toxicology of cefazolin in animals. J Infect Dis1973; 128(Suppl): S379–81.
14.
BarzaM. The nephrotoxicity of cephalosporins: An overview. J Infect Dis1978; 137(Suppl): S60–73.
15.
MarshFP. Do cephalosporins potentiate or antagonize aminoglycoside nephrotoxicity?J Antimicrob Chemother1978; 4: 103–11.